GlucoTrack's stock jumped about 90% after hours to $3.87, but the article gives no company news, so the report does not change its outlook.
The article only reports an after-hours 90% price jump for GlucoTrack without any company announcement. Its tiny market value and lack of company news make the move look speculative, so I do not change the company's outlook.
Greenland Mines' shares rose about 10% to $12.32 in the article, but no company news is given, so this does not change the company's outlook.
Bone Biologics' stock rose about 8.6% to $0.55, yet the article provides no company-level news, so this does not change how we read the company.
Senti Biosciences' shares increased about 7.9% to $0.36, but absent company details the report does not change the company's outlook.
BioRestorative Therapies' stock rose about 6.9% to $2.78, but the article lists only price movement and no company news, so the outlook stays the same.
Armata Pharmaceuticals' shares rose about 6.9% to $3.89, but without company announcements the article does not change how we read the company.
Follow GlucoTrack (GCTK) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GCTK